Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease

Radioimmunotherapy (RIT) with α-emitting radionuclides is an attractive approach for the treatment of minimal residual disease because the short path lengths and high energies of α-particles produce optimal cytotoxicity at small target sites while minimizing damage to surrounding normal tissues. Pre...

Full description

Saved in:
Bibliographic Details
Main Authors: Park, Steven I., Shenoi, Jaideep, Pagel, John M., Hamlin, Don K., Wilbur, D. Scott, Orgun, Nural, Kenoyer, Aimee L., Frayo, Shani, Axtman, Amanda, Bäck, Tom, Lin, Yukang, Fisher, Darrell R., Gopal, Ajay K., Green, Damian J., Press, Oliver W.
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2010
Subjects:
Lymphoid Neoplasia
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2993626/
https://ncbi.nlm.nih.gov/pubmed/20702781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-05-282327
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items